Association of Near Infrared Spectroscopy With Interstage Outcomes
NCT ID: NCT06538571
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2024-07-01
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Skeletal Muscle Oxygenation in Patients With Chronic Kidney Disease Stage 2, 3 and 4
NCT05250167
A Comparison of Renal vs Limb NIRS for Predicting Cardiac Surgery Associated Acute Kidney Injury
NCT06705855
Assessment of AI Prediction Models in Prediction of Acute Kidney Injury in Critical Patients
NCT06857188
Kidney Uptake at F-18 FDG PET/CT Studies and Renal Function Status
NCT06268067
Evaluating Novel Biomarkers in Acute Kidney Injury
NCT01573104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NIRS use
Patients will have renal near infrared spectroscopy recorded in clinic.
Near infrared spectroscopy
Noninvasive monitor for venous saturation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Near infrared spectroscopy
Noninvasive monitor for venous saturation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants with single ventricle heart disease and parallel circulation
* Infants who are awaiting the Glenn operation
* Infants who are outpatient
Exclusion Criteria
* Inpatients
* Infants with history of skin injury from the near infrared spectroscopy sensor inpatient
* Infants with ongoing hyperbilirubinemia
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Advocate Hospital System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joshua Wong
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joshua Wong, MD
Role: PRINCIPAL_INVESTIGATOR
Advocate Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Advocate Childrens Hospital
Oak Lawn, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00111841
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.